Back to Search
Start Over
Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against Tuberculosis▿
- Publication Year :
- 2010
- Publisher :
- American Society for Microbiology (ASM), 2010.
-
Abstract
- Murine models of M ycobacterium tuberculosis infection are essential tools in drug discovery. Here we describe a fast standardized 9-day acute assay intended to measure the efficacy of drugs against M. tuberculosis growing in the lungs of immunocompetent mice. This assay is highly reproducible, allows good throughput, and was validated for drug lead optimization using isoniazid, rifampin, ethambutol, pyrazinamide, linezolid, and moxifloxacin.
- Subjects :
- Drug
Tuberculosis
media_common.quotation_subject
Moxifloxacin
Antitubercular Agents
Pharmacology
Mycobacterium tuberculosis
Mice
Acetamides
Drug Discovery
medicine
polycyclic compounds
Isoniazid
Animals
Pharmacology (medical)
Experimental Therapeutics
Tuberculosis, Pulmonary
Ethambutol
Oxazolidinones
media_common
Aza Compounds
Inhalation Exposure
biology
business.industry
Linezolid
Reproducibility of Results
Pyrazinamide
biochemical phenomena, metabolism, and nutrition
medicine.disease
biology.organism_classification
bacterial infections and mycoses
Mice, Inbred C57BL
Disease Models, Animal
Infectious Diseases
Quinolines
Rifampin
business
Immunocompetence
Rifampicin
medicine.drug
Fluoroquinolones
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....8aa251ef00c3eb7cdd8507239dd5a8cd